An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province

Overview

The epidemic caused by the new coronavirus appeared in December 2019 and spread rapidly, and it has had a serious impact on the social development and people's lives in the world. On February 11, 2020, the World Health Organization (WHO) named the infectious disease caused by the virus COVID-19. my country classifies it as a Class B infectious disease, and controls it as a Class A infectious disease. In order to effectively respond to the epidemic, on January 23, 2020, Zhejiang Province first launched a first-level response to major public health emergencies across the country. Some patients with new coronary pneumonia, especially critically ill patients, may go to the emergency department first. Emergency medical staff must identify and isolate patients with new coronary pneumonia in a timely manner while ensuring the treatment of critically ill patients. People face greater unknowns and challenges in the anti-epidemic work. this research Participating in the prevention and control of the new crown pneumonia epidemic through investigations in the emergency department of Zhejiang Province Related conditions, to further improve the hospital's emergency medical service capabilities for reference.

References： 1. Huang CL, Wang YM, Li XW, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China\[J\]. Lancet, 2020, 395(10223): 497-506. DOI:10.1016/s0140-6736(20)30183-5. 2. Zhu N, Zhang DY, Wang WL, et al. A novel coronavirus from patients with pneumonia in China, 2019\[J\]. N Engl J Med, 2020, 382(8): 727- 733. DOI:10.1056/nejmoa2001017. 3. Gupta M, Abdelmaksoud A, Jafferany M, et al. COVID-19 and economy\[J\]. Dermatol Ther, 2020: e13329. DOI:10.1111/dth.13329. 4. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome- related coronavirus: classifying 2019-nCoV and naming it SARS- CoV-2 \[J\]. Nat Microbiol, 2020, 5(4):536-544. DOI:10.1038/s41564- 020-0695-z. 5. Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges\[J\]. Int J Antimicrob Agents, 2020, 55(3): 105924. DOI:10.1016/j.ijantimicag.2020.105924.

Conditions